Cover Image

Dacarbazine, Cisplatin, and Interferon-alfa-2b with or without Interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Show other versions (10)

Background: Based on phase II trial results, chemoimmunotherapy combinations have become the preferred treatment for patients with metastatic melanoma in many institutions. This study was performed to determine whether interleukin-2 (IL-2) as a component of chemoimmunotherapy influences survival of...

Full description

Saved in:
Bibliographic Details
Main Authors: Keilholz, Ulrich (Author) , Schadendorf, Dirk (Author)
Format: Article (Journal)
Language:English
Published: September 21, 2016
In: Journal of clinical oncology
Year: 2005, Volume: 23, Issue: 27, Pages: 6747-6755
ISSN:1527-7755
DOI:10.1200/JCO.2005.03.202
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2005.03.202
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2005.03.202
Get full text
Author Notes:Ulrich Keilholz, Cornelis J.A. Punt, Martin Gore, Wim Kruit, Poulam Patel, Danielle Lienard, Jose Thomas, Thomas M. Proebstle, Alexander Schmittel, Dirk Schadendorf, Thierry Velu, Sylvie Negrier, Ulrich Kleeberg, Frederic Lehman, Stefan Suciu, and Alexander M.M. Eggermont
Search Result 2
Cover Image

Patterns of constitutive and IFN-γ inducible expression of HLA class II molecules in human melanoma cell lines by Rodríguez, Teresa (Author) , Méndez, Roman (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 3
Cover Image

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes by Blöthner, Sandra (Author) , Hemminki, Kari (Author) , Chen, Bowang (Author) , Ugurel, Selma (Author) , Schadendorf, Dirk (Author) , Kumar, Rajiv (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 4
Cover Image

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study by Schadendorf, Dirk (Author) , Ugurel, Selma (Author) , Figl, Adina (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 5
Cover Image

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatol... by Ugurel, Selma (Author) , Schadendorf, Dirk (Author) , Figl, Adina (Author) , Rittgen, Werner (Author) , Delorme, Stefan (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 6
Cover Image

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma by Ugurel, Selma (Author) , Sucker, Antje (Author) , Rittgen, Werner (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 7
Cover Image

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma by Fink, Wolfram (Author) , Figl, Adina (Author) , Figl, Robert (Author) , Ugurel, Selma (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 8
Cover Image

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients by Ugurel, Selma (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 10
Cover Image

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2 by Becker, Jürgen C. (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Show all versions (11)

Similar Items